Best Alzheimer's disease Treatment Clinics and Prices in Republic of Korea for Australians

Alzheimer's antibody treatments in South Korea, such as lecanemab, carry risks of Amyloid-Related Imaging Abnormalities (ARIA). These involve brain swelling or micro-haemorrhages. Most cases show no symptoms, but some cause headaches or confusion. Specialist clinics like Severance Hospital use MRI monitoring to manage these risks safely.

• Brain swelling: ARIA-E represents fluid build-up in the brain tissue.
• Micro-haemorrhages: ARIA-H involves small spots of bleeding on the brain surface.
• Genetic risk: Global trials show APOE4 gene carriers face up to 33% higher risk.
• Infusion reactions: Patients may experience fever, chills, or blood pressure changes during treatment.

Bookimed Expert Insight: South Korea's digital healthcare infrastructure offers a safety advantage for managing antibody side effects. Hospitals like Seoul National University Bundang Hospital use the BESTcare digital system to track patient data. This helps neurologists monitor MRI schedules and infusion reactions with fewer medical errors. For complex cases, choosing a JCI-accredited centre like Severance Hospital ensures international safety standards during the first 6 months.

Patient Consensus: Families in the Republic of Korea often worry about distinguishing treatment-related confusion from dementia progression. They recommend choosing a centre with clear protocols for MRI frequency. They also suggest checking if the team has experience managing ARIA-related symptoms like dizziness or visual changes.

South Korea employs a structured, government-backed approach to Alzheimer's diagnosis. It uses the culturally tailored Cognitive Impairment Screening Test (CIST) instead of Western standards. High-density Amyloid PET imaging starts earlier in the diagnostic pathway than in many Western protocols. This allows for precise, early identification of amyloid-beta proteins.

• Screening tools: The CIST replaces text-based MMSE with picture-based items for better accuracy.
• Early detection: Formal recognition of subjective cognitive decline results in regular 1–2 year follow-ups.
• Monitoring: The national JOY-ALZ registry tracks real-world data and therapy outcomes.
• Imaging priority: Specialised guidelines require frequent MRI and PET monitoring for therapy-related imaging abnormalities.

Bookimed Expert Insight: South Korean clinics demonstrate a significant focus on neurology. Five of the country's top hospitals appear on Newsweek's Best Hospitals list. Specialists like Dr Yeon Jung Kim at Asan Medical Center use family-inclusive consultations with high-volume research. This expertise, combined with arterial stem cell infusion at clinics like RE:YOUTH, offers unique diagnostic intersections. These are rarely seen in Western primary care.

Patient Consensus: Patients find that Korean clinics often coordinate multidisciplinary assessments during a single visit. These assessments involve neurologists and imaging specialists. They note that the process is heavily imaging-based. PET scans and biomarker testing are discussed much earlier than in Australia.

South Korea offers amyloid-targeting monoclonal antibodies like Lecanemab and regenerative therapies. These disease-modifying treatments slow cognitive decline in early-stage Alzheimer's. Leading JCI-accredited centres in Seoul integrate these with PET imaging for precise amyloid plaque staging.

• Regenerative medicine: RE:YOUTH clinic specialises in arterial stem cell therapy for dementia.
• Drug therapies: Lecanemab (Leqembi) targets amyloid-β protofibrils to slow disease progression.
• Precision diagnostics: Centres use PET imaging like florbetaben to identify eligible patients.
• Specialist expertise: Dr Byung-hee Lee is a founding member for interventional neurology.

Bookimed Expert Insight: South Korea combines traditional academic neurology with specialised regenerative clinics. Major hospitals like Severance Hospital handle 1.6 million outpatients with standard care. In contrast, smaller centres like RE:YOUTH limit intake to 2 patients daily. This focus allows for personalised attention during complex arterial stem cell infusions.

Doctors in South Korea administer donanemab via intravenous infusion every 4 weeks. Treatment takes place in JCI-accredited hospitals or specialised neurology centres. Patients receive the 30-minute infusion under medical supervision. This allows monitoring for amyloid-related imaging abnormalities.

• Infusion method: Medication enters the bloodstream directly through a 30-minute intravenous drip.
• Clinical setting: Dedicated infusion centres at major hospitals manage the process.
• Safety monitoring: Specialists use MRI scans to check for brain swelling or bleeding.
• Patient selection: Neurologists confirm Alzheimer's pathology and APOE4 gene status before starting.
• Treatment frequency: Standard protocols require one hospital visit every 4 weeks for infusions.

Bookimed Expert Insight: South Korea is a global neurology hub with 76 clinics served. Leading facilities like Asan Medical Center integrate dementia care with researchers from the Korean Dementia Association. Patients benefit from specialists like Dr Yeon Jung Kim, who trained at New York-Presbyterian Hospital. This global training helps ensure Australian patients receive treatment following protocols used in the USA.

Patient Consensus: Patients note that treatment in South Korea requires careful logistics for regular hospital visits. They emphasise planning for recovery time and repeated MRI scans after each infusion session.

South Korea provides structured medical and social support for Alzheimer's patients through the National Dementia Plan. Major centres such as Severance Hospital and Asan Medical Center offer specialised neurology care. Support includes diagnostic screenings, dedicated dementia care specialists, and long-term care insurance subsidies for eligible residents.

• Specialised neurology units: JCI-accredited facilities like Gangnam Severance Hospital provide expert neurological and neurosurgical care.
• Clinical diagnostics: Clinics use high-resolution CT and ECG to monitor cognitive and physical health.
• Integrated safety systems: SNUBH uses the BESTcare digital system to reduce medical errors during treatment.
• Expert physician involvement: Specialists such as Dr Yeon Jung Kim include families in treatment discussions.

Bookimed Expert Insight: South Korea's national support network is extensive. However, many community-based subsidies apply only to residents. International patients should prioritise hospitals with Global Healthcare Accreditation (GHA). Seoul National University Bundang Hospital is one such hospital. These institutions are vetted for how they handle the needs of patients travelling from abroad.

Patient Consensus: International families should not expect automatic access to local community programs. Patients note it is essential to arrange personal caregiver support. It is also important to confirm English-speaking staff availability in Korea before arrival.